Health ❯ Pharmaceuticals ❯ Drug Safety

Regulatory Affairs

FDA FDA Approval FDA Warning Letters Experimental Drugs Pharmacovigilance Quality Control European Medicines Agency FDA Guidelines

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

A confirmatory trial submitted this year showed excess thrombotic events versus usual care.

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections